Rep. Biggs Introduces the Medical Innovation Acceleration Act
May 22, 2020
May 22, 2020
GILBERT, Arizona, May 22 -- Rep. Andy Biggs, R-Arizona, issued the following news release:
Congressman Biggs introduced the Medical Innovation Acceleration Act, which would eliminate Food and Drug Administration (FDA) oversight of low-risk, non-invasive medical devices.
Non-invasive medical devices can be used to identify and track a wide range of conditions, such as diabetes or high blood pressure. Future devices will likely be used to predict genetic susceptibility to . . .
Congressman Biggs introduced the Medical Innovation Acceleration Act, which would eliminate Food and Drug Administration (FDA) oversight of low-risk, non-invasive medical devices.
Non-invasive medical devices can be used to identify and track a wide range of conditions, such as diabetes or high blood pressure. Future devices will likely be used to predict genetic susceptibility to . . .